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doi:10.1016/j.jmii.2010.08.007Background: Sphingomonas paucimobilis is rarely isolated from clinical specimens and it is
associated with a great variety of infections. The aim of this study is to investigate the micro-
biological and clinical features of S paucimobilis infection in southern Taiwan.
Methods: S paucimobilis isolates from the microbiology laboratory of Chi-Mei Medical Center
and their relevant clinical data from October 2005 to October 2009 were retrospectively
reviewed.
Results: A total of 55 patients with documented S paucimobilis infections were identified.
Among them, 29 (52.7%) have community-acquired infections and 13 of them presented with
primary bacteremia (44.8%). Multivariate logistic regression showed that community-acquired
infection [adjusted odds ratio 13.473, 95% confidence interval (CI) 1.79e101.41, pZ 0.01],
diabetes mellitus (adjusted odds ratio 7.03, 95% CI 1.16e42.66, pZ 0.03), and alcoholism
(adjusted OR 10.87, 95% CI 1.00e117.69, pZ 0.05) were significant risk factors for S paucimo-
bilis primary bacteremia. Most of those who have health care-associated S paucimobilis
infections presented with pneumonia (10 of 26, 38.5%) and only 7.7% presented with
catheter-related infection. The overall mortality rate was 5.5%.
Conclusion: Community-acquired S paucimobilis infections were not uncommon, mainly pre-
senting with primary bacteremia. Multivariate analysis showed that community-acquired infec-
tion, diabetes mellitus, and alcoholism were significant risk factors for primary bacteremia.
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Sphingomonas paucimobilis (formerly known as Pseudo-
monas paucimobilis and CDC group IIk-1) is a strictly
aerobic, nonspore-forming, nonfermentative Gram-nega-
tive bacillus. It is characterized by catalase and oxidase
activity, yellow pigment production, and slow motility with
single polar flagellum.1 This organism is ubiquitous in the
natural environment (especially in water and soil), and it is
used for bioremediation of the environment for its ability to
decompose aromatic compounds.2 It has also been recov-
ered from diverse sources in the hospital environment,
including hospital water system, respiratory therapy
equipment, and laboratory instruments. Nosocomial
outbreaks of S paucimobilis have been reported and
considered to originate from contaminated hospital envi-
ronment and equipment.3e5
S paucimobilis is an opportunistic pathogen and identi-
fication of the organism from clinical specimen is rare. It
has been isolated from blood, sputum, urine, wound, bile,
cerebrospinal fluid, vagina, and cervix. A great variety of
community-acquired and health care-associated infections
have been reported, in which catheter-related infection is
the most common form.6 Although S paucimobilis infection
occurred occasionally at our hospital, case mortality had
been noted. The aim of this study is to investigate the
clinical features, risk factors, and outcomes of patients
with S paucimobilis infection in a tertiary hospital in
southern Taiwan.
Materials and methods
Setting
This study was performed at a 1,200-bed tertiary hospital in
southern Taiwan. All of the clinical specimens in this
hospital are handled by a central microbiology laboratory.
Patients
Clinical data were collected retrospectively from the
medical records of patients with documented S paucimobilis
infection from October 2005 to October 2009. Relevant data
obtained included demographic characteristic, underlying
disease, comorbidity, clinical presentation, recent invasive
procedure, infection source, laboratory data, bacteriology
data, and clinical outcome.
Bacterial identification and antimicrobial
susceptibility testing
These organisms were identified from various clinical
specimens with the use of Bactec Model 9240 (Becton-
Dickinson, Sparks, MD, USA) or the API 20NE system (bio-
Me´rieux, Marcy L’Etoile, France). Susceptibility testing of
these isolates to eight antimicrobial agents was performed
with the use of disk diffusion method. These agents
included ceftazidime, cefpirome, imipenem-cilastatin,
ciprofloxacin, gentamicin, amikacin, piperacillin-tazo-
bactam, and sulfamethoxazole-trimethoprim (SMX-TMP).
Staphylococcus aureus (American Type Culture Collection)ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas
aeruginosa ATCC 27853 were used as control strains in the
tests. The breakpoints of susceptibility were according to
the recommendation of Clinical and Laboratory Standards
Institute.7
Definitions
S paucimobilis infection was defined as a patient presented
with systemic inflammatory response syndrome and a posi-
tive culture for S paucimobilis. Primary bacteremia was
defined as S paucimobilis bacteremia with signs of sepsis
but without an identifiable focus of infection. Catheter-
related infection was indicated by a positive blood culture
without an apparent source of bacteremia except the
central venous catheter. Fluid or pus aspirated from deep
tissue or abscess (excluding body fluid) was regarded as soft
tissue infection. However, a positive culture of a superficial
wound swab was considered as colonization, in the absence
of systemic inflammatory response syndrome. Positive
culture of specimens obtained from head and neck region,
including surgical specimen and fine needle aspiration,
were regarded as head and neck infection. Pneumonia is
diagnosed by clinical symptoms and chest X-ray findings.
The sputum culture was defined as colonization if Gram
stain yields more than 10 epithelial cells per low-power
field or less than 25 polymorphonuclear cell per low-power
field.
Health care-associated infection was defined as an
infection that developed in a patient at least 48 hours after
hospitalization, with the organism being isolated from an
obviously infected focus. Antibiotic therapy was defined as
inappropriate if an antibiotic agent active against S pauci-
mobilis (as determined by in vitro susceptibility testing)
was not administered during the first 48 hours after the
diagnosis of infection.
Statistical analyses
Comparisons between groups were made with c2 or Fisher’s
exact test for categorical variables and Student t test
for continuous variables. A p value <0.05 was considered
significant. Comparison between patient with primary
bacteremia and nonprimary bacteremia was done to iden-
tify risk factors for primary bacteremia. Risk factors with
a p value less than 0.1 were chosen for multivariate logistic
regression, using stepwise forward method. Age, gender,
and malignancy (which has been reported as a risk factors
for bacteremia)8 were also included for multivariate anal-
ysis. Analyses were performed using commercial statistical
software SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
Results
Demographic characteristics
A total of 63 isolates of S paucimobilis were identified from
61 patients from October 2005 to October 2009 in our
hospital. Their medical records were reviewed and six
patients were excluded because of colonization only (two
wound swabs and four sputum specimens). Only
Sphingomonas paucimobilis infection 291nonduplicate isolates were included for analysis. Conse-
quently, 55 patients with documented S paucimobilis
infection were included in this study. The data was
summarized in Table 1.
Among these patients, 29 patients (52.7%) have commu-
nity-acquired S paucimobilis infection, whereas the rest has
health care-associated infections. Primary bacteremia
(27.3%) was the most common type of infection, followed by
pneumonia (21.8%) and head and neck infection (21.8%).
There were only two cases of catheter-related infections.
Comparisons between community-acquired and health
care-associated infections were summarized in Table 1.
Significantly, more patients presented with primary
bacteremia in community-acquired group (44.8% vs. 7.7%,
p< 0.01) and with pneumonia in health care-associated
group (38.5% vs. 6.9%, pZ 0.01). The health care-associ-
ated group had more patients with underlying chronic heart
disease (26.9% vs. 3.4%, pZ 0.02).
Potential risk factors were compared between patient
with primary bacteremia and nonprimary bacteremia
(Table 2), a p value of less than 0.05 was used to identify
the risk factors. This univariate analysis revealed
community-acquired infection (p< 0.01), diabetes melli-
tus (pZ 0.01), and alcoholism (p< 0.01) as risk factors for
S paucimobilis primary bacteremia (Table 2). In addition,Table 1 Demographic characteristics and clinical manifestation
Characteristics All, n (%) Community-a
Patients 55 29
Age (mean SD) 50.0 25.6 43.9 22.9
Gender (male) 34 (61.8) 19 (65.5)
Source of infection
Primary bacteremia 15 (27.3) 13 (44.8)
Catheter-related infection 2 (3.6) 0
Pneumonia/empyema 12 (21.8) 2 (6.9)
Urinary tract infection 2 (3.6) 0
Soft tissue infection 10 (18.2) 7 (24.1)
CNS infection 2 (3.6) 1 (3.4)
Head and neck infection 12 (21.8) 6 (20.7)
Underlying diseases
Diabetes mellitus 13 (23.6) 7 (24.1)
Malignancy 8 (14.5) 5 (17.2)
Chronic heart disease 8 (14.5) 1 (3.4)
Chronic lung disease 5 (9.1) 2 (6.9)
Chronic kidney disease 0 0
Cirrhosis 3 (5.5) 2 (6.9)
Steroid usage 4 (7.3) 3 (10.3)
Alcoholism 6 (10.9) 5 (17.2)
Treatment
Inappropriate 42 (76.4) 24 (82.8)
Complications/outcomes
Septic shock 5 (9.1) 3 (10.3)
Acute respiratory failure 14 (25.5) 4 (13.8)
Acute renal failure 6 (10.9) 1 (3.4)
ICU stay 15 (27.3) 4 (13.8)
Mortality 3 (5.5) 1 (3.4)
a Comparison between community-acquired infection and health ca
CNSZ central nervous system; ICUZ intensive care unit; SDZ standsteroid usage (pZ 0.06), age, gender, and malignancy
were also included for multivariate logistic regression
analysis, which showed that community-acquired infection
[adjusted odds ratio 13.47, 95% confidence interval (CI)
1.79e101.41, pZ 0.01], diabetes mellitus (adjusted OR
7.03, 95% CI 1.16e42.66, pZ 0.03), and alcoholism
(adjusted OR 10.87, 95% CI 1.00e117.69, pZ 0.05) were
significant risk factors for primary bacteremia (Table 3).
Antimicrobial susceptibility testing
Susceptibility of S paucimobilis varied from 72.7% to 94.5%
for all the antimicrobial agents tested (Table 4). Of note, 3
of 55 (5.5%) isolates of S paucimobilis were resistant to
imipenem-cilastatin. Community-acquired isolates had
a significantly lower susceptibility to SMX-TMP than health
care-acquired isolates (72.4% vs. 96.2%, pZ 0.03).
Treatment and outcome
Most patients received inappropriate antibiotics initially (42
of 55, 76.4%) but were switched to appropriate antibiotics
after the availability of culture results and susceptibility
testing. Cure was achieved in the two cases with catheter
infection with appropriate antibiotics, and one requireds of 55 patients with S paucimobilis infections
cquired, n (%) Health care-associated, n (%) pa
26
56.8 27.1 0.06
15 (57.7) 0.55
2 (7.7) <0.01
2 (7.7) 0.21
10 (38.5) 0.01
2 (7.7) 0.22
3 (11.5) 0.30
1 (3.8) 1.00
6 (23.1) 0.83
6 (23.1) 0.93
3 (11.5) 0.71
7 (26.9) 0.02
3 (11.5) 0.66
0 d
1 (3.8) 1.00
1 (3.8) 0.61
1 (3.8) 0.20
18 (69.2) 0.24
2 (7.7) 1.00
10 (38.5) 0.06
5 (19.2) 0.09
11 (42.3) 0.03
2 (7.7) 0.60
re-associated infection.
ard deviation.
Table 2 Characteristics of patients with primary bacteremia caused by S paucimobilis
Characteristics Primary bacteremia, n (%) Nonprimary bacteremia, n (%) p
Patients 15 40
Age (mean SD) 55.2 28.1 48.0 24.6 0.35
Gender (male) 8 (53.3) 26 (65.0) 0.43
Source of patient
Community acquired 13 (86.7) 16 (40.0) <0.01
Underlying diseases
Diabetes mellitus 7 (46.7) 6 (15.0) 0.01
Malignancy 3 (20.0) 5 (12.5) 0.67
Chronic heart disease 3 (20.0) 5 (12.5) 0.67
Chronic lung disease 3 (20.0) 2 (5.0) 0.12
Cirrhosis 2 (13.3) 1 (2.5) 0.18
Steroid usage 3 (20.0) 1 (2.5) 0.06
Alcoholism 5 (33.3) 1 (2.5) <0.01
Complications and outcomes
Septic shock 2 (13.3) 3 (7.5) 0.61
Acute respiratory failure 2 (13.3) 12 (30.0) 0.30
Acute renal failure 0 6 (15.0) 0.17
ICU stay 2 (13.3) 13 (32.5) 0.19
Mortality 0 3 (7.5) 0.55
ICUZ intensive care unit; SDZ standard deviation.
292 H.-S. Toh et al.removal of the catheter, whereas the other patient
retained his Port-A catheter.
Five (9.1%) of the patients had septic shock, 14 (25.5%)
had acute respiratory failure, and 6 (10.9%) had acute
renal failure. A larger portion of the patients in health
care-associated group required intensive care (42.3% vs.
13.8%, pZ 0.03). There was no difference in the incidence
of complication between the two groups. Despite inap-
propriate initial antibiotic treatment and development of
complication, the overall mortality rate was low (3 of 55,
5.5%). One of them was a 58-year-old man with diabetes,
who presented to the emergency department with
disturbance of consciousness and subsequent culture of
the cerebrospinal fluid yielded S paucimobilis. The patient
died of septic shock with multiorgan failure (including
acute renal failure and disseminated intravascular coag-
ulation) after 10 days. The other two patients were a 22-
year-old woman with seizure disorder and a 48-year-old
man with intracerebral hemorrhage, and both developed S
paucimobilis ventilator-associated pneumonia during
hospitalization.Table 3 Multivariate analysis of risk factors for acquiring prima
Risk factors Multivariate analysis
Crude odds ratio (95% CI)
Community-acquired 9.75 (1.93e49.15)
Diabetes mellitus 4.958 (1.31e18.84)
Alcoholism 19.5 (2.04e186.24)
a Odds ratio adjusted for age, gender, steroid use, and malignancy.
CIZ confidence interval.Discussion
S paucimobilis was first reported to cause human infection
in 1979 and was named Pseudomonas paucimobilis. It was
renamed Sphingomonas paucimobilis in 1990 based on
phylogenetic data.1 It is well known as a waterborne
organism and its infections being attributable to contami-
nated water sources have been reported.9e11 S paucimo-
bilis can cause a variety of infections in both healthy
people and immunocompromised hosts. Clinical syndrome
associated with S paucimobilis include primary bacteremia,
intravascular catheter infections, peritoneal dialysis-asso-
ciated peritonitis,12 urinary tract infection, biliary tract
infection, cutaneous infection,13 ventilator-associated
pneumonia,14 meningitis,15 myositis,16 osteomyelitis,17
septic arthritis,18,19 endophthalmitis,20,21 cervical
adenitis,9 bromohidrosis,22 and diarrheal disease.6 Most S
paucimobilis infections reported in the literature were
either hospital acquired or related to nosocomial out-
breaks.3e5,23e26 In our study, 52.7% of our patients have
community-acquired infection, which is much higher thanry bacteremia caused by S paucimobilis
Adjusted odds ratio (95% CI)a p
13.47 (1.79e101.41) 0.01
7.03 (1.16e42.66) 0.03
10.87 (1.00e117.69) 0.05
Table 4 Antimicrobial susceptibility of 55 strains of S paucimobilis
Antibiotics All, n (%) Community-acquired, n (%) Health care-associated, n (%) pa
Ceftazidime 42 (76.4) 24 (82.8) 18 (69.2) 0.23
Cefpirome 43 (78.2) 25 (86.2) 18 (69.2) 0.19
Piperacillin-tazobactam 40 (72.7) 19 (65.5) 21 (80.7) 0.21
Imipenem-cilastatin 52 (94.5) 28 (96.6) 24 (92.3) 0.60
Ciprofloxacin 41 (74.5) 22 (75.9) 19 (73.1) 0.81
Gentamicin 48 (87.3) 24 (82.8) 24 (92.3) 0.43
Amikacin 50 (90.9) 25 (86.2) 25 (96.2) 0.36
SMX-TMP 46 (83.6) 21 (72.4) 25 (96.2) 0.03
a Comparison between community-acquired infection and health care-associated infection.
Among the 55 strains, 29 strains were isolated from community-acquired infection and the remaining 26 strains were from health care-
associated infections.
SMX-TMPZ sulfamethoxazole-trimethoprim.
Sphingomonas paucimobilis infection 293those reported previously (9.7%e31.0%).6,8 Most of the
community-acquired infection presented with primary
bacteremia (13 of 29, 44.8%) and mainly occurred in
immunocompromised hosts.
According to Cheong et al.,6 the most common type of
infection was catheter-related infection (34.8%) followed
by primary bacteremia (26.1%), continuous ambulatory
peritoneal dialysis peritonitis (13.0%), and gastrointestinal
infection (8.7%). However, among our patients with health
care-associated S paucimobilis infection, the most common
presentation was pneumonia and most of them were
ventilator-associated pneumonia.
S paucimobilis bacteremia had been reported mainly in
patients with indwelling devices or in immunocompromised
host, especially those with neutropenia11,27 and hemato-
poietic stem cell transplantation.26,28,29 A recent study by
Lin et al.8 focused on S paucimobilis bacteremia stated that
the most common comorbidities were malignancy (57.1%)
and immunosuppressant use (40.5%). However, the most
common comorbidities of their own series were malignancy
(56.3%) and diabetes mellitus (31.3%). Although there was
a higher rate of catheter-related bloodstream infection
(33.3%) after cases combining with the literature, the
incidence rate of their own series was 18.8% (3 of 16). In
contrast, in our study, there were only two cases of cath-
eter-related infection. Most of our patient with bacteremia
presented with primary bacteremia and most of them were
categorized as community-acquired infections. Multivariate
logistic regression showed that community-acquired infec-
tion, diabetes mellitus, and alcoholism were risk factors for
primary bacteremia of S paucimobilis infection. Based on
a geographical study of the nationwide distribution of
melioidosis in Taiwan, southern Taiwan has the highest rate
of positivity of Burkholderia pseudomallei in soil samples
and the highest prevalence of the disease.30 Our series has
a higher percentage of community-acquired S paucimobilis
infections compared with other studies.3,6,8 Whether there
is any geographical difference in distribution of this path-
ogen in the environment (water or soil) required further
study.
Most of the strains of S paucimobilis in this survey are
usually susceptible to aminoglycosides, carbapenems, and
SMX-TMP. They are usually resistant to penicillins and first-
generation cephalosporins because of the production of
chromosomally encoded beta-lactamase production.31However, susceptibility to the third-generation cephalo-
sporins and fluoroquinolones varied. The resistance rates of
S paucimobilis to various antibiotics in our study are similar
to previous study.6,8 Only three isolates of S paucimobilis
were imipenem resistant but remained susceptible to cef-
pirome, amikacin, and SMX-TMP. A high rate of resistance to
SMX-TMP was found in the community strains compared
with health care-associated strains (27.4% vs. 3.8%,
pZ 0.03). Whether this is a result of selection pressure
from the wide usage of SMX-TMP in treating common
community-acquired infections needs more investigations
to provide a plausible explanation.
Aminoglycoside plus a third-generation cephalosporin
have been recommended as suitable antibiotics for treat-
ment of S paucimobilis infections in previous study.3 In our
study, carbapenem may be another good treatment choice
because of its high susceptibility rate (94.5%) for S pauci-
mobilis. Besides, for those who had catheter-related
infections (including those with peritoneal dialysis-related
peritonitis), catheter removal is suggested if poor clinical
response to medical therapy is noted, although good clin-
ical outcome without catheter removal has been reported.6
Among our patient, 9.1% (5 of 55) of them developed
septic shock during presentation. In contrast, 18.8% (3 of
16) of the patients in the study by Lin et al.8 also had septic
shock as a result of S paucimobilis bacteremia. Despite the
probability of development of complications, the overall
prognosis of S paucimobilis infection is usually favorable.
Although more patients with health care-associated infec-
tion requiring intensive care in our study, there was no
statistical difference about the development of complica-
tions between community-acquired and health care-asso-
ciated S paucimobilis infections.
In a study done in Korea, less than half (10 of 23, 43.5%)
of the patients received inappropriate initial empirical
antibiotic therapy.6 All patients survived despite inappro-
priate initial antimicrobials. Most (76.4%) of our patients
received inappropriate antibiotics initially. Although two of
the three deceased patients received inappropriate anti-
biotics initially, the overall outcome for patients with
inappropriate antibiotics was favorable with a survival rate
of 95.2% (40 of 42). The mortality in our case series was
believed to be associated to the underlying diseases of the
patients rather than inappropriate therapy. Although fatal
cases were noted in our patients, S paucimobilis was
294 H.-S. Toh et al.considered to have limited virulence,32 probably related to
the lack of lipopolysaccharide A in its cell wall.33 These
findings may explain the relatively favorable clinical
outcome of the patients with S paucimobilis infections.
In conclusion, community-acquired S paucimobilis
infections are not uncommon, mainly present with primary
bacteremia. Univariate and multivariate analysis showed
that community-acquired infection, diabetes mellitus, and
alcoholism were significant risk factors for primary
bacteremia. These findings markedly contrasted with those
of previous studies from other countries. The association
between much higher probability of community-acquired S
paucimobilis infection and environmental exposure is worth
further study.
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